Her2 positive breast cancer spread to liver

page_title_detailed

Metastatic breast cancer to the liver

In some people, breast cancer cells may travel outside the breast to the liver.

  • 10 Min. Read
  • Medical Review: Hayley Knollman MD

general_content

In some people, breast cancer cells may travel outside the breast to the liver. This is called liver metastasis, or liver mets. When breast cancer cells spread to distant parts of the body, it’s called metastatic breast cancer, which includes stage IV breast cancer. While breast cancer can spread to any part of the body, the four most common sites are the bones, liver, lungs, and brain.

About half of people diagnosed with metastatic breast cancer develop liver metastases. It can be difficult to diagnose liver metastasis, because most of the time, liver mets do not cause new symptoms.

Researchers are still studying why breast cancer cells travel to the liver and develop new tumors.

image_row

Her2 positive breast cancer spread to liver

on_this_page

On This Page

  • About the liver
  • What is liver metastasis?
  • Who gets it?
  • Symptoms
  • How is it diagnosed?
  • Monitoring
  • Treatments
  • Coping
  • Clinical trials
  • Additional resources

general_content

About the liver

Your liver is located on the right upper side of your abdomen, protected by the rib cage. It is an important organ because it:

  • Cleans toxins from your blood
  • Helps digest fat
  • Processes nutrients from the food you eat, so your body can use them well
  • Processes the medicine you take, including cancer medicines

A healthy liver doesn’t just keep your body functioning well. It also helps your body process cancer treatment. Keeping your liver as healthy as possible is important in treating cancer. Detecting and treating liver metastasis early, if possible, is part of this. Alcohol, some over-the-counter dietary supplements, and some herbal products can cause damage to the liver. If you already take vitamins or supplements, or are planning to start a new supplement, be sure to tell your doctor. Some may interact with your cancer treatment.

Even with liver mets, the liver can continue to function normally. If tumors eventually interfere with the liver’s ability to function, it is possible for liver metastasis to cause liver failure.

general_content

What is liver metastasis?

In breast cancer, liver metastasis means that breast cancer cells travel to the liver to form tumors. These tumors can affect how your liver works. It’s possible to have just one tumor in the liver, but most people who get liver metastasis develop more than one tumor.

general_content

Who gets liver metastasis?

After the bones and lungs, the liver is the third most common place for breast cancer to spread. About half of people diagnosed with metastatic breast cancer develop liver metastasis. Women with metastatic breast cancer to the liver usually have metastasis in other parts of the body as well, but not always. Breast cancer that spreads to the liver can include cancers with different cell characteristics, including hormone receptor-positive, HER2 -positive, or triple-negative breast cancers. It’s possible for people of any background or age to develop liver metastasis.

general_content

What are the symptoms of liver metastasis?

Liver metastases often do not cause symptoms, but signs of it could be abnormal liver function testing, or abnormal appearance of the liver on a scan.

Other symptoms of liver metastasis include:

  • Right upper abdominal pain
  • Belly fullness
  • Loss of appetite
  • Fatigue or feeling weak
  • Fever
  • Itchy skin, or yellowing of the eyes or skin (a condition called jaundice)
  • Swollen legs

Remember to always tell your oncologist about changes you notice in your body. Many of these symptoms are not specific to liver metastasis. Your doctors can help explain what you’re experiencing and how to manage it or order tests for more information.

If you have already been diagnosed with liver metastasis, it’s important to know about some serious symptoms that suggest the liver is not working as well as it used to, which may mean that your treatment plan may need to be changed or adjusted. Call your doctor right away if you experience:

  • Sudden weight loss
  • New pain, swelling, or discomfort in the legs or belly
  • Jaundice, a condition that causes the skin or the whites of the eyes to turn yellow
  • Vomiting more than twice a day for more than a day, or vomiting blood

If liver metastasis is causing symptoms like these, your doctor may recommend a different treatment or change the dose of your current treatment.

general_content

How is liver metastasis diagnosed?

Doctors use different techniques for diagnosing liver metastasis. Sometimes, blood tests that check liver function can show a higher-than-normal level of liver enzymes, or elevated bilirubin, a yellow pigment that’s produced and passed through the liver as red blood cells break down. Imaging tests, such as a CT or CAT scan, MRI, PET scan, or ultrasound can also be used to look for metastases. These tests create pictures of your liver and can show whether cancer has spread there.

Sometimes an imaging test isn’t enough for a doctor to know you have liver metastasis. A liver biopsy can confirm breast cancer involvement in the liver. Your doctor may recommend a biopsy, during which a radiologist will insert a needle through the skin of your right upper abdomen to obtain a sample of liver tissue. A pathologist then tests the piece of liver for breast cancer cells.

general_content

Monitoring liver metastasis

If you are diagnosed with liver metastasis, you and your care team will decide on a treatment plan. That plan will also include regular tests that show your doctors how treatments are working and if the tumors are shrinking, growing, or staying the same. Watching for changes in the cancer allows you and your doctor to continue making treatment decisions, while working to manage or minimize side effects.

Tests to monitor liver metastasis

Your doctor may use some of the same tests to monitor liver metastasis that were used to diagnose them. These can include blood tests and imaging tests:

  • Blood tests can show changes in the level of liver enzymes in your blood or find proteins (tumor markers) that have broken away from tumors and entered your blood. Either may suggest the cancer is growing or spreading.
  • Imaging tests — for example, a CT or CAT scan, MRI, PET scan, or ultrasound — can create pictures of your liver and show the location of cancer. By comparing the pictures over time, doctors can see whether liver metastases are growing, shrinking, or changing in other ways.

How often you need testing

How often you get which tests for liver metastasis depends on your diagnosis and your doctor’s preferences. But it’s common for doctors to recommend imaging tests every 2-6 months. Your doctor may also recommend additional tests if you experience new or more serious symptoms or side effects. Ask your doctor how often they recommend you have certain tests, and why.

general_content

How are liver metastases treated?

We know that learning you have metastatic breast cancer to the liver can be upsetting and scary. But there are several ways to treat liver metastasis and control symptoms and side effects.

Liver metastasis is typically treated with systemic treatments (treatments that impact the whole body), such as chemotherapy and targeted therapies. For some people, immunotherapy is also an option. Less often, local treatments are used. The local therapies you may be offered include:

  • Radiation therapy
  • Chemoembolization, in which chemotherapy is delivered directly to tumors
  • Ablation therapy, in which tumors are injected with electricity, freezing cold gas, or alcohol to destroy them
  • Surgery

If the cancer causes blocks in bile ducts that help the liver get rid of waste, a procedure known as a biliary stent may be recommended to unblock the duct and allow the bile to flow again, which helps with digestion.

Factors that affect treatment

How your care team treats liver metastasis is largely based on whether the cancer is hormone receptor-positive, HER2-positive, or triple-negative. Other factors your oncologist will consider include:

  • Your age
  • The size of the tumor or tumors
  • Symptoms you are currently experiencing
  • What cancer treatments you’ve had in the past
  • Features of the cancer
  • Your menopausal status
  • How healthy you currently are, aside from cancer
  • Whether you also have metastatic breast cancer in other parts of your body, such as the brain, bones, or lungs
  • Organ function, such as kidney and liver function

general_content

How to cope

We know that coping with cancer is emotionally draining. Many people find some relief by talking about their experience with a licensed professional therapist or with a peer support group. If you’re interested in either of these, ask a social worker or patient navigator from your healthcare team if they can connect you with resources. These professionals are tuned in to the local cancer support landscape and should be able to recommend support groups or counselors who meet at your cancer treatment center or nearby. They may also be able to recommend professionals or groups that are accessible online from any location.

You may also find that it helps to:

  • Talk with other women diagnosed with liver mets in online groups.
  • Meet up with others living with liver mets in your community or in organized support groups.
  • Get insights from others in text or phone conversations through professional helplines. We encourage you to reach out to our Helpline by filling out our online form to be matched with a trained volunteer who has been diagnosed with metastatic breast cancer and is coping with a similar experience.

general_content

Clinical trials

In addition to receiving standard treatments for metastatic breast cancer to the liver, you may also be eligible to join a clinical trial looking at new, promising medicines, or at new ways of delivering treatments. Joining a clinical trial may seem like an uncertain way to treat cancer. But in most cases, treatment through a trial allows you to have exposure to new medicines and to be closely monitored by the trial team.

To learn more about clinical trial eligibility and safety, or to search for trials you might be able to join, visit our clinical trials section.

general_content

A liver metastasis diagnosis can leave you feeling exhausted and overwhelmed. Below you’ll find articles, personal stories, and downloadable resources to help you make sense of the basics of your diagnosis, from understanding the disease to coping with the lifestyle changes that come with it.

related_resources_article_carousel

related articles and posts

Scalp cooling to help prevent hair loss

Scalp cooling is a therapy that helps some people lose less or no hair during chemotherapy treatment.

Early menopause

8/26/22 | BY: Ann Honebrink

If you are premenopausal or perimenopausal, breast cancer treatments — including surgery to remove ovaries, chemotherapy, and hormonal therapy — may cause your menstrual periods to stop for a while or, in some cases, permanently.

Chemobrain

8/26/22 | BY: Arash Asher

If you’ve been diagnosed with cancer and you’ve had trouble concentrating on a task, remembering words or directions, doing several things at once, or recalling a date or phone number, you may be experiencing cognitive changes after cancer treatment, often called “chemobrain.”

Insomnia and fatigue

8/19/22 | BY: Dianne L. Hyman

Cancer-related insomnia and fatigue are very common with a breast cancer diagnosis and treatment, and can develop for many reasons. Insomnia is difficulty falling and staying asleep. Cancer-related fatigue is significant tiredness, exhaustion, and weakness that is not relieved after sleeping.

Heart health

8/15/22 | BY: Lori Ranallo

Heart problems are a rare but serious side effect of some medicines used to treat breast cancer. These medicines can damage the heart muscle and its ability to pump blood as well as it should.

Hand-foot syndrome

8/15/22 | BY: Lori Ranallo

Hand-foot syndrome, also called palmar-plantar erythrodysesthesia, is a skin reaction on the palms of the hands and soles of the feet. Certain cancer medicines can cause hand-foot syndrome. But even if you are given a cancer medicine known to cause hand-foot syndrome, there are things you can do to lessen the chances of developing it.

Pain

8/15/22 | BY: Lori Ranallo

It’s very common to worry about whether breast cancer and its treatment will cause pain. People diagnosed with any stage of breast cancer may experience pain caused by the cancer or its treatment. Still, not everyone experiences pain.

Neutropenia

8/15/22 | BY: Evelyn Robles-Rodriguez

Neutropenia is a condition caused by lower-than-normal amounts of neutrophils, a type of white blood cell. Chemotherapy can cause neutropenia because it kills rapidly dividing cells, including cancer cells and healthy white blood cells. Other cancer treatments can also cause neutropenia.

Neuropathy

8/15/22 | BY: Lori Ranallo

Neuropathy is a medical term used to describe pain or discomfort caused by damage to the body’s peripheral nervous system. The peripheral nervous system includes the nerves that control movement and sensations in the arms and legs. Some breast cancer treatments can damage these nerves, causing neuropathy.

Nausea and vomiting

8/15/22 | BY: Evelyn Robles-Rodriguez

Nausea is a feeling of sickness or discomfort in the stomach that may come with an urge to vomit. It's a common side effect of some types of breast cancer treatment.

3_callout_columns

about_this_page_tabbed_module

About this page

Glossary

About LBBC

  • 3-dimensional radiation therapy
  • 4-hydroxytamoxifen
  • ablation
  • abnormal
  • Abraxane
  • absolute risk
  • AC regimen
  • AC-T regimen
  • AC-T-T regimen
  • AC-Taxol regimen
  • AC-TH regimen
  • accelerated partial-breast irradiation
  • action study
  • acupoint
  • acupressure
  • acupuncture
  • acupuncture needle
  • acupuncture point
  • acupuncture point injection
  • acupuncturist
  • acustimulation
  • acute
  • acute pain
  • adenocarcinoma
  • adenopathy
  • adenosis
  • adjunct agent
  • adjunct therapy
  • adjunctive therapy
  • adjuvant therapy
  • advance directive
  • advanced practice nurse
  • adverse effect
  • aerobic exercise
  • agent study
  • aggravating factor
  • aggressive
  • AJCC staging system
  • Alkeran
  • alkylating agent
  • Allegra
  • allopathic medicine
  • alopecia
  • amifostine
  • aminoglutethimide
  • amitriptyline
  • anabolic steroid
  • analgesic
  • anaplastic
  • anastrozole
  • ancillary test
  • anemia
  • anesthesia
  • anesthesiologist
  • angiogenesis
  • angiogenesis inhibitor
  • antagonist
  • anthracycline
  • anti-anxiety medicine
  • anti-idiotype vaccine
  • anti-inflammatory
  • antibody-dependent cellular cytotoxicity
  • antibody therapy
  • anticachexia
  • anticancer antibiotic
  • anticancer therapy
  • anticonvulsant
  • antidepressant
  • antiemetic
  • antiestrogen
  • antifolate
  • antigen-presenting cell vaccine
  • antihormone therapy
  • antimetabolite
  • antimitotic agent
  • antineoplastic
  • antitumor
  • anxiety
  • anxiolytic
  • Anzemet
  • APN
  • apocrine gland
  • apoptosis
  • aprepitant
  • areola
  • Aromasin
  • aromatase inhibitor
  • aromatherapy
  • arthralgia
  • ascites
  • aspirate
  • aspiration
  • assay
  • asthenia
  • asymptomatic
  • atypia
  • atypical ductal hyperplasia
  • atypical hyperplasia
  • atypical lobular hyperplasia
  • avoidance
  • axillary lymph node
  • axillary lymph node dissection
  • BAK gel
  • balloon catheter radiation
  • baseline
  • behavior modification
  • best practice
  • BI-RADS
  • Biafine cream
  • bias
  • bilateral
  • bilateral breast cancer
  • bilateral prophylactic mastectomy
  • bilateral salpingo-oophorectomy
  • biofeedback
  • biologic
  • biopsy
  • biopsy specimen
  • biotherapy
  • bisphosphonate
  • bisphosphonate-associated osteonecrosis
  • blinded study
  • blood-brain barrier
  • blood-brain barrier disruption
  • blood cell count
  • blood chemistry study
  • board certified oncology pharmacy specialist
  • body image
  • body mass index
  • bolus dose
  • bone density
  • bone metastasis
  • bone mineral density scan
  • bone scan
  • bone-seeking radioisotope
  • brachytherapy
  • brain metastasis
  • BRCA1
  • BRCA2
  • BRCAPro
  • breast carcinoma in situ
  • breast-conserving surgery
  • breast density
  • breast duct
  • breast duct endoscopy
  • breast lobe
  • breast lobule
  • breast reconstruction
  • breast self-exam
  • Brief Pain Inventory
  • cachexia
  • CAF regimen
  • calcification
  • cancer vaccine
  • candidiasis
  • capecitabine
  • carboplatin
  • carcinogen
  • carcinoma
  • carcinoma in situ
  • carcinomatous meningitis
  • carcinosis
  • carcinostatic
  • cardiotoxicity
  • caregiver
  • carmustine
  • case-control study
  • case report
  • case series
  • CAT scan
  • CBC
  • cell
  • cell-cycle regulation
  • cell proliferation
  • central nervous system
  • central nervous system metastasis
  • central nervous system prophylaxis
  • central venous access catheter
  • cetuximab
  • cevimeline
  • chaplain
  • charged-particle radiation therapy
  • chemoembolization
  • chemoimmunotherapy
  • chemoprevention
  • chemoprevention study
  • chemoprotective
  • chemoradiation
  • chemosensitivity
  • chemosensitivity assay
  • chemosensitizer
  • chemotherapeutic agent
  • chemotherapy
  • chest wall
  • chest X-ray
  • Chinese meridian theory
  • chronic
  • chronic pain
  • cisplatin
  • Claus model
  • clergy
  • clinical
  • clinical breast exam
  • clinical practice guidelines
  • clinical researcher
  • clinical resistance
  • clinical series
  • clinical stage
  • clinical staging
  • clinical study
  • clinical trial
  • clinician
  • clodronate
  • CMF regimen
  • cognition
  • cognitive behavior therapy
  • cognitive therapy
  • cohort
  • cohort study
  • combination chemotherapy
  • comedo carcinoma
  • comfort care
  • Coming Out
  • Community Advisory Board
  • comorbidity
  • compassionate use trial
  • complementary and alternative medicine
  • complementary medicine
  • complete metastasectomy
  • complete remission
  • complete response
  • complex decongestive therapy
  • compliance
  • complication
  • compression garment
  • computed tomography scan
  • concomitant
  • concurrent therapy
  • condition
  • consolidation therapy
  • constitutional acupuncture
  • continuum of care
  • contract research organization
  • contraindication
  • contralateral
  • contrast material
  • control group
  • controlled clinical trial
  • controlled study
  • conventional medicine
  • conventional therapy
  • cope
  • coping skills
  • core biopsy
  • core needle biopsy
  • corticosteroid
  • counseling
  • COX inhibitor
  • cryoablation
  • cryopreservation
  • cryosurgery
  • CT scan
  • cultural competency
  • cumulative dose
  • cumulative exposure
  • cure
  • cutaneous
  • cutaneous breast cancer
  • cyclophosphamide
  • cyclosporine
  • CYP2D6 inhibitor
  • cystosarcoma phyllodes
  • cytopenia
  • cytotoxic
  • cytotoxic chemotherapy
  • Cytoxan
  • Data and Safety Monitoring Board
  • DCIS
  • de novo
  • debulking
  • definitive surgery
  • definitive treatment
  • dehydration
  • denosumab
  • depression
  • diagnosis
  • diagnostic mammogram
  • diagnostic procedure
  • diagnostic technique
  • diagnostic trial
  • diameter
  • diarrhea
  • diaziquone
  • DIEP flap
  • dietary counseling
  • dietary supplement
  • dietitian
  • differentiation
  • diffuse
  • digital mammography
  • diphenhydramine
  • discharge
  • disease progression
  • disease-specific survival rate
  • distant cancer
  • distant metastasis
  • Distant recurrence
  • distress
  • DNR order
  • docetaxel
  • dolasetron
  • dose
  • dose-dense chemotherapy
  • dose-dependent
  • dose-limiting
  • dose-rate
  • double-blinded
  • doxorubicin
  • drain
  • dronabinol
  • droperidol
  • drug interaction
  • drug resistance
  • drug therapy
  • drug tolerance
  • duct
  • ductal carcinoma
  • ductal carcinoma in situ
  • ductal lavage
  • duloxetine
  • durable power of attorney
  • dysfunction
  • dysgeusia
  • dyspepsia
  • dyspnea
  • early menopause
  • early-stage breast cancer
  • edema
  • EEG biofeedback
  • efficacy
  • Eklund displacement views
  • electroacupuncture
  • electron beam
  • eligibility criteria
  • Ellence
  • emesis
  • emetic
  • endocrine
  • endocrine therapy
  • endpoint
  • energy healing
  • enteral nutrition
  • epidemiology
  • epirubicin
  • ER+
  • ER-
  • ER
  • ER-PR-HER2/neu-
  • eribulin mesylate
  • erythema
  • estradiol
  • estrogen
  • estrogen blocker
  • estrogen receptor
  • estrogen receptor-negative
  • estrogen receptor-positive
  • estrogen receptor test
  • estrogen replacement therapy
  • etanidazole
  • etidronate
  • everolimus
  • Evista
  • excision
  • excisional biopsy
  • exemestane
  • expanded access trial
  • experimental
  • extranodal
  • false-negative test result
  • false-positive test result
  • familial cancer
  • family medical history
  • Faslodex
  • fast-neutron beam radiation
  • fatigue
  • FDA
  • febrile neutropenia
  • FEC regimen
  • Femara
  • fentanyl citrate
  • fentanyl sublingual spray
  • fertility
  • fexofenadine
  • fibroadenoma
  • fibrocystic breast changes
  • fiducial marker
  • film mammography
  • fine-needle aspiration biopsy
  • first-degree relative
  • first-line therapy
  • five-year survival rate
  • fluorouracil
  • fluoxetine
  • FNA biopsy
  • focal
  • Food and Drug Administration
  • Fosamax
  • fractionation
  • fulvestrant
  • functional magnetic resonance imaging
  • gadolinium
  • Gail model
  • gallium scan
  • gamma irradiation
  • Gamma Knife therapy
  • gamma ray
  • Gelclair
  • gemcitabine
  • gene
  • gene expression profile
  • gene therapy
  • general anesthesia
  • generalized anxiety disorder
  • generic
  • genetic
  • genetic counseling
  • genetic marker
  • genetic marker of susceptibility
  • genetic predisposition
  • genetic profile
  • genetic susceptibility
  • genetic testing
  • genetic testing
  • genetics
  • genome
  • genome-wide association study
  • genomic profile
  • genomic test
  • genomics
  • gland
  • Good Clinical Practice
  • goserelin
  • grade
  • grading
  • granisetron
  • gross description
  • Halaven
  • hazard ratio
  • healing touch
  • Health Insurance Portability and Accountability Act
  • healthcare provider
  • healthcare proxy
  • healthy control
  • helical computed tomography
  • HER2/neu
  • Herceptin
  • hereditary
  • hereditary mutation
  • heteronormative
  • high-dose chemotherapy
  • high-dose radiation
  • high-energy proton therapy
  • high grade
  • high-risk cancer
  • HIPPA
  • histologic examination
  • histology
  • historic cohort study
  • historical control subject
  • homeopathic medicine
  • hormonal therapy
  • hormone
  • hormone receptor
  • hormone receptor test
  • hormone replacement therapy
  • hormone responsive
  • hormone therapy
  • hospice
  • hot flash
  • human epidermal growth factor receptor 2
  • human participant protection regulations
  • hydroxydaunorubicin
  • hyperalimentation
  • hypercalcemia
  • hyperfractionated radiation therapy
  • hyperfractionation
  • hyperplasia
  • hypersensitivity
  • hypofractionated radiation therapy
  • hypofractionation
  • hypoxia
  • ibandronate
  • ibuprofen
  • idiopathic
  • image-guided radiation therapy
  • imaging
  • imaging procedure
  • immune adjuvant
  • immune function
  • immune response
  • immune system
  • immune system tolerance
  • immunization
  • immunoassay
  • immunocompromised
  • immunodeficiency
  • immunohistochemistry
  • immunology
  • immunomodulation
  • immunosuppression
  • immunotherapy
  • implant
  • implant displacement views
  • implant radiation therapy
  • implantable pump
  • in situ
  • incidence
  • incision
  • incisional biopsy
  • indication
  • indolent
  • induction therapy
  • infection
  • infertile
  • infertility
  • infiltrating breast cancer
  • infiltrating ductal carcinoma
  • inflammation
  • inflammatory breast cancer
  • informed consent
  • infusion
  • ingestion
  • inherited
  • iniparib
  • injection
  • inoperable
  • insomnia
  • Institutional Review Board
  • intensification therapy
  • intensity-modulated radiation therapy
  • interfering thought
  • internal mammary lymph nodes
  • internal radiation therapy
  • International Unit
  • internist
  • interstitial radiation therapy
  • intervention
  • intervention group
  • intra-arterial
  • intracarotid infusion
  • intradermal
  • intraductal breast papilloma
  • intraductal carcinoma
  • intrahepatic
  • intrahepatic infusion
  • intramuscular
  • intramuscular injection
  • intraoperative radiation therapy
  • intraoperative ultrasound
  • intratumoral
  • intravasation
  • intravenous
  • intravenous infusion
  • intravenous injection
  • intrusive thought
  • intrusive thoughts
  • invasive breast cancer
  • invasive cancer
  • invasive procedure
  • investigational
  • investigator
  • ionizing radiation
  • ipsilateral
  • IRB
  • irradiated
  • irradiation
  • irreversible toxicity
  • ixabepilone
  • joint pain
  • Karnofsky Performance Status
  • laboratory test
  • lapatinib
  • laser
  • laser surgery
  • laser therapy
  • lassitude
  • late effects
  • late-stage cancer
  • latent
  • laxative
  • LEEP
  • legal aid organization
  • lesion
  • lethargy
  • letrozole
  • leukopenia
  • levels of evidence
  • Lexapro
  • libido
  • lidocaine
  • ligation
  • linac
  • linear accelerator
  • lipoma
  • lisofylline
  • liver metastasis
  • liver scan
  • living will
  • lobaplatin
  • lobe
  • lobectomy
  • lobular carcinoma
  • lobular carcinoma in situ
  • lobule
  • local anesthesia
  • local cancer
  • local therapy
  • localization
  • localized
  • locally advanced cancer
  • locally recurrent cancer
  • lomustine
  • loop electrosurgical excision procedure
  • loop excision
  • lorazepam
  • low grade
  • lubricant
  • lumbar puncture
  • lumpectomy
  • lung metastasis
  • luteinizing hormone-releasing hormone agonist
  • lymph
  • lymph gland
  • lymph node
  • lymph node dissection
  • lymph node drainage
  • lymph node mapping
  • lymph vessel
  • lymphadenectomy
  • lymphadenopathy
  • lymphangiogram
  • lymphangiography
  • lymphatic basin
  • lymphatic fluid
  • lymphatic mapping
  • lymphatic system
  • lymphatic vessel
  • lymphedema
  • lymphography
  • lymphoscintigraphy
  • Lyrica
  • lytic lesion
  • macrocalcification
  • magnetic resonance imaging
  • magnetic resonance perfusion imaging
  • magnetic resonance spectroscopic imaging
  • mainstream medicine
  • maintenance therapy
  • male breast cancer
  • malignancy
  • malignant
  • malignant pleural effusion
  • malnutrition
  • mammary
  • mammary dysplasia
  • mammary gland
  • mammogram
  • mammography
  • MammoSite
  • Mammotome
  • mantle field
  • MAO inhibitor
  • margin
  • marker
  • mass
  • massage therapy
  • mastectomy
  • mastitis
  • maternal
  • maximum tolerated dose
  • mean survival time
  • measurable disease
  • medial supraclavicular lymph node
  • median
  • median survival time
  • Medicaid
  • medical castration
  • medical device
  • medical nutrition therapy
  • medical oncologist
  • Medicare
  • medicine
  • medullary breast carcinoma
  • mega-voltage linear accelerator
  • megestrol
  • melphalan
  • meningeal metastasis
  • menopause
  • menorrhagia
  • menstrual cycle
  • menstrual period
  • menstruation
  • mental health
  • mental health counselor
  • meperidine hydrochloride
  • meridian
  • mesna
  • meta-analysis
  • metallic
  • metastasectomy
  • metastasis
  • metastasize
  • metastatic
  • methotrexate
  • metoclopramide
  • metronomic therapy
  • microcalcification
  • micrometastasis
  • microscopic
  • milk duct
  • mind/body exercise
  • mindfulness relaxation
  • Miraluma test
  • mitigate
  • modified radical mastectomy
  • molecular marker
  • molecular medicine
  • molecular risk assessment
  • molecularly targeted therapy
  • monoamine oxidase inhibitor
  • monoclonal antibody
  • morbidity
  • mortality
  • MRI
  • MRSI
  • MTD
  • mTOR
  • mucositis
  • multicenter study
  • multicentric breast cancer
  • multidisciplinary
  • multidisciplinary opinion
  • multidrug resistance
  • multidrug resistance inhibition
  • multifocal breast cancer
  • music therapy
  • mutation
  • mutation carrier
  • myalgia
  • myelosuppression
  • nanoparticle paclitaxel
  • narcotic
  • National Cancer Institute
  • National Center for Complementary and Alternative Medicine
  • National Institutes of Health
  • natural history study
  • naturopathy
  • nausea
  • NCCAM
  • NCI
  • NCI clinical trials cooperative group
  • needle biopsy
  • needle localization
  • needle-localized biopsy
  • negative axillary lymph node
  • negative test result
  • neoadjuvant therapy
  • neoplasm
  • nerve
  • nerve block
  • neurocognitive
  • neurologic
  • neuropathy
  • neurotoxicity
  • neurotoxin
  • neutropenia
  • NIH
  • nipple
  • nipple discharge
  • nitrosourea
  • NMRI
  • node-negative
  • node-positive
  • nodule
  • nonblinded
  • nonconsecutive case series
  • noninvasive
  • nonmalignant
  • nonmetastatic
  • nonprescription
  • nonrandomized clinical trial
  • nonsteroidal anti-inflammatory drug
  • nonsteroidal aromatase inhibitor
  • nontoxic
  • normal range
  • normative
  • NP
  • NPO
  • NSAID
  • nuclear grade
  • nuclear magnetic resonance imaging
  • nuclear medicine scan
  • nurse
  • nurse practitioner
  • nutrition
  • nutrition therapy
  • nutritional counseling
  • nutritional status
  • nutritional supplement
  • nutritionist
  • obese
  • objective improvement
  • objective response
  • observation
  • observational study
  • obstruction
  • off-label
  • olaparib
  • oncologist
  • oncology
  • oncology nurse
  • oncology pharmacy specialist
  • oncolysis
  • ondansetron
  • onset of action
  • oophorectomy
  • open biopsy
  • open label study
  • open resection
  • operable
  • opiate
  • opioid
  • opportunistic infection
  • oral
  • organ
  • orthodox medicine
  • osteolytic
  • osteonecrosis of the jaw
  • osteopenia
  • osteoporosis
  • OTC
  • outcome
  • outpatient
  • ovarian
  • ovarian ablation
  • ovarian cancer
  • ovarian suppression
  • ovary
  • over-the-counter
  • overall survival rate
  • overdose
  • overexpress
  • overweight
  • ovulation
  • oxycodone hydrochloride
  • PA
  • paclitaxel
  • paclitaxel albumin-stabilized nanoparticle formulation
  • paclitaxel-loaded polymeric micelle
  • Paget disease of the nipple
  • pain threshold
  • palliation
  • palliative care
  • palliative therapy
  • palmar-plantar erythrodysesthesia
  • palonosetron hydrochloride
  • palpable disease
  • palpation
  • palpitation
  • pamidronate
  • panic
  • papillary tumor
  • Paraplatin
  • parenteral nutrition
  • paroxetine hydrochloride
  • PARP
  • PARP inhibitor
  • partial-breast irradiation
  • partial mastectomy
  • partial oophorectomy
  • partial remission or partial response
  • pastoral counselor
  • paternal
  • pathologic fracture
  • pathological stage
  • pathological staging
  • pathologist
  • pathology report
  • patient advocate
  • Paxil
  • peau d'orange
  • pedigree
  • peer-review process
  • peer-reviewed scientific journal
  • perfusion magnetic resonance imaging
  • perimenopausal
  • periodic neutropenia
  • perioperative
  • peripheral neuropathy
  • peripheral venous catheter
  • personal health record
  • personal medical history
  • personalized medicine
  • Pertuzumab
  • PET scan
  • pharmacist
  • phase I/II trial
  • phase I trial
  • phase II/III trial
  • phase II trial
  • phase III trial
  • phase IV trial
  • phlebotomy
  • photon beam radiation therapy
  • phyllodes tumor
  • physical examination
  • physical therapist
  • physical therapy
  • physician
  • physician assistant
  • physiologic
  • PI3 kinase inhibitor
  • pilocarpine
  • pilot study
  • placebo
  • placebo-controlled
  • plastic surgeon
  • plastic surgery
  • population study
  • positive axillary lymph node
  • positive test result
  • positron emission tomography scan
  • post-traumatic stress disorder
  • postmenopausal
  • postoperative
  • postremission therapy
  • potentiation
  • power of attorney
  • PR
  • PR+
  • PR-
  • practitioner
  • precancerous
  • preclinical study
  • predictive factor
  • pregabalin
  • premalignant
  • premature menopause
  • premenopausal
  • prescription
  • prevention
  • preventive
  • preventive mastectomy
  • primary care
  • primary care doctor
  • primary endpoint
  • primary therapy
  • primary treatment
  • primary tumor
  • Principal investigator
  • prochlorperazine
  • progesterone
  • progesterone receptor
  • progesterone receptor-negative
  • progesterone receptor-positive
  • progesterone receptor test
  • progestin
  • prognosis
  • prognostic factor
  • progression
  • progression-free survival
  • progressive disease
  • Prolia
  • proliferative index
  • promegapoietin
  • prophylactic
  • prophylactic mastectomy
  • prophylactic oophorectomy
  • prophylactic surgery
  • prophylaxis
  • prospective
  • prospective cohort study
  • prosthesis
  • protective factor
  • protein
  • protein-bound paclitaxel
  • protein expression
  • protein expression profile
  • protocol
  • proton
  • proton magnetic resonance spectroscopic imaging
  • pruritus
  • psychiatrist
  • psychological
  • psychologist
  • psychosocial
  • psychotherapy
  • PTSD
  • pump
  • punch biopsy
  • qi
  • qigong
  • quadrantectomy
  • quality assurance
  • quality of life
  • radiation
  • radiation brachytherapy
  • radiation dermatitis
  • radiation fibrosis
  • radiation necrosis
  • radiation nurse
  • radiation oncologist
  • radiation physicist
  • radiation surgery
  • radiation therapist
  • radiation therapy
  • radical lymph node dissection
  • radical mastectomy
  • radioactive
  • radioactive drug
  • radioactive seed
  • radioisotope
  • radiologic exam
  • radiologist
  • radiology
  • radionuclide
  • radionuclide scanning
  • radiopharmaceutical
  • radiosensitization
  • radiosensitizer
  • radiosurgery
  • radiotherapy
  • raloxifene
  • raloxifene hydrochloride
  • randomization
  • randomized clinical trial
  • receptor
  • RECIST
  • reconstructive surgeon
  • reconstructive surgery
  • recreational therapy
  • recurrence
  • recurrent cancer
  • referral
  • reflexology
  • refractory
  • refractory cancer
  • regimen
  • regional
  • regional anesthesia
  • regional cancer
  • regional chemotherapy
  • regional lymph node
  • regional lymph node dissection
  • registered dietician
  • regression
  • rehabilitation
  • rehabilitation specialist
  • relapse
  • relative survival rate
  • relaxation technique
  • remission
  • remission induction therapy
  • remote brachytherapy
  • research nurse
  • research study
  • resectable
  • resected
  • resection
  • residual disease
  • resistant cancer
  • resorption
  • respite care
  • response rate
  • retrospective cohort study
  • retrospective study
  • risk factor
  • Rubex
  • salpingo-oophorectomy
  • salvage therapy
  • samarium 153
  • sargramostim
  • scalpel
  • scan
  • scanner
  • scintigraphy
  • scintimammography
  • sclerosing adenosis
  • screening
  • screening mammogram
  • second-line therapy
  • second-look surgery
  • second primary cancer
  • secondary cancer
  • secrete
  • sedative
  • segmental mastectomy
  • selection bias
  • selective estrogen receptor modulator
  • selective serotonin reuptake inhibitor
  • sentinel lymph node
  • sentinel lymph node biopsy
  • sentinel lymph node mapping
  • sepsis
  • sequential AC/Taxol-Trastuzumab regimen
  • sequential treatment
  • SERM
  • sertraline
  • Serzone
  • sestamibi breast imaging
  • sexuality
  • sibling
  • side effect
  • silicone
  • simple mastectomy
  • simulation
  • Single-agent therapy
  • sleep disorder
  • social service
  • social support
  • social worker
  • sodium thiosulfate
  • soft tissue
  • solid tumor
  • somatic
  • somatic mutation
  • sorafenib
  • specialist
  • specificity
  • spiculated mass
  • spinal anesthesia
  • spinal block
  • spiral CT scan
  • spirituality
  • sporadic cancer
  • SSRI
  • stable disease
  • stage
  • stage 0 breast carcinoma in situ
  • stage 0 disease
  • stage I breast cancer
  • stage IA breast cancer
  • stage IB breast cancer
  • stage II breast cancer
  • stage II breast cancer
  • stage IIA breast cancer
  • stage IIB breast cancer
  • stage III breast cancer
  • stage III lymphedema
  • stage IIIA breast cancer
  • stage IIIB breast cancer
  • stage IIIC breast cancer
  • stage IV breast cancer
  • staging
  • stamina
  • standard of care
  • standard therapy
  • statistically significant
  • stent
  • stereotactic biopsy
  • stereotactic radiosurgery
  • sterile
  • sternum
  • steroid
  • stress
  • strontium
  • study agent
  • subcutaneous
  • subcutaneous port
  • subjective improvement
  • subset analysis
  • supplemental nutrition
  • supplementation
  • support group
  • supportive care
  • supraclavicular lymph node
  • surgeon
  • surgery
  • surgical biopsy
  • surgical menopause
  • surgical oncologist
  • survival rate
  • symptom
  • symptom management
  • symptomatic
  • synergistic
  • synthetic
  • syringe
  • systemic
  • systemic chemotherapy
  • systemic disease
  • systemic therapy
  • TAC regimen
  • tai chi
  • tailored intervention
  • talk therapy
  • tamoxifen
  • targeted therapy
  • taxane
  • Taxol
  • Taxotere
  • Tc 99m sulfur colloid
  • technician
  • terminal disease
  • therapeutic
  • therapeutic touch
  • therapy
  • thermography
  • thiethylperazine
  • thiotepa
  • third-line therapy
  • thrush
  • time to progression
  • tinnitus
  • tissue
  • tissue flap reconstruction
  • TNM staging system
  • tomography
  • tomotherapy
  • topical
  • topical chemotherapy
  • topoisomerase inhibitor
  • total estrogen blockade
  • total mastectomy
  • total nodal irradiation
  • total parenteral nutrition
  • toxic
  • toxicity
  • tracer
  • traditional acupuncture
  • tranquilizer
  • transdermal
  • transfusion
  • transitional care
  • translational research
  • trastuzumab
  • trauma
  • treatment field
  • trigger
  • trigger point acupuncture
  • triple-negative breast cancer
  • tumescent mastectomy
  • tumor
  • tumor antigen vaccine
  • tumor board review
  • tumor burden
  • tumor debulking
  • tumor load
  • tumor marker
  • tumor volume
  • Tykerb
  • ulcer
  • ulceration
  • ultrasound-guided biopsy
  • ultrasound/ultrasonography
  • ultraviolet radiation therapy
  • uncontrolled study
  • undifferentiated
  • unilateral
  • unilateral salpingo-oophorectomy
  • unresectable
  • unresected
  • upstaging
  • urticaria
  • VACB
  • vaccine therapy
  • vacuum-assisted biopsy or vacuum-assisted core biopsy
  • Valium
  • vancomycin
  • vandetanib
  • vascular endothelial growth factor-antisense oligonucleotide
  • vascular endothelial growth factor receptor tyrosine kinase inhibitor
  • vein
  • Velban
  • venipuncture
  • venous sampling
  • Versed
  • vertebroplasty
  • vinorelbine
  • vital
  • vomit
  • watchful waiting
  • wedge resection
  • Wellcovorin
  • Western medicine
  • WGA study
  • white blood cell
  • whole cell vaccine
  • whole genome association study
  • wide local excision
  • wire localization
  • wound
  • X-ray therapy
  • Xanax
  • Xeloda
  • xerostomia
  • Xgeva
  • yoga
  • ziconotide
  • Zinecard
  • Zofran
  • zoledronic acid
  • Zoloft
  • Zometa

Her2 positive breast cancer spread to liver

Living Beyond Breast Cancer is a national nonprofit organization that seeks to create a world that understands there is more than one way to have breast cancer. To fulfill its mission of providing trusted information and a community of support to those impacted by the disease, Living Beyond Breast Cancer offers on-demand emotional, practical, and evidence-based content. For over 30 years, the organization has remained committed to creating a culture of acceptance — where sharing the diversity of the lived experience of breast cancer fosters self-advocacy and hope. For more information, learn more about our programs and services.

How long can you live when breast cancer spreads to liver?

Background: Liver metastases from breast cancer are associated with a poor prognosis (median survival < 6 months). A subgroup of these patients with no dissemination in other organs may benefit from surgery.

What Happens When breast cancer spreads to the liver?

Liver Metastasis: When breast cancer spreads to the liver, it often doesn't cause symptoms. If a liver metastasis does cause symptoms, they can include pain or discomfort in the mid-section, fatigue and weakness, weight loss or poor appetite, and fever.

Where does HER2 breast cancer usually spread to?

Usually in HER2-positive metastatic breast cancer, common places of spread include the liver, lung, bones, lymph nodes, and unfortunately the brain.

How common is it for breast cancer to metastasize to the liver?

About 50% of people diagnosed with metastatic breast cancer develop liver metastases, and 5% to 12% of these people develop liver metastases as the main site of breast cancer recurrence.